Axsome Therapeutics (NASDAQ: AXSM) lists two 6,000-share transactions in Form 144

Rhea-AI Filing Summary

Axsome Therapeutics, Inc. submitted a Form 144 notice regarding proposed or completed sales of Common stock. The filing lists two transactions of 6,000 shares each: one dated 05/29/2026 with $1,400,783.00 and one dated 06/01/2026 with $1,381,798.00. The filing identifies Charles Schwab & Co., Inc. as the broker and shows 51,459,766 shares outstanding as of 06/02/2026.

Insights

Securities Filings Analyst

Form 144 lists two 6,000-share transactions and broker details.

Form 144 is a seller notice under Rule 144; the excerpt names Charles Schwab & Co., Inc. as the broker and records two 6,000-share transactions with the dollar amounts shown. The filing also includes an "Exercise and Hold" entry dated 11/19/2024.

Cash-flow treatment for the listed exercise is shown as Cash in the excerpt. Subsequent regulatory or broker confirmations would be in other filings if required.

Key Figures

Transaction - 05/29/2026: 6,000 shares Proceeds - 05/29/2026: $1,400,783.00 Transaction - 06/01/2026: 6,000 shares +3 more

6 metrics

Transaction - 05/29/2026 6,000 shares Sale dated 05/29/2026

Proceeds - 05/29/2026 $1,400,783.00 Dollar amount listed with 05/29/2026 transaction

Transaction - 06/01/2026 6,000 shares Sale dated 06/01/2026

Proceeds - 06/01/2026 $1,381,798.00 Dollar amount listed with 06/01/2026 transaction

Shares outstanding 51,459,766 shares as of 06/02/2026

Exercise date 11/19/2024 Listed as "Exercise and Hold" date

Key Terms

Form 144, Exercise and Hold, Charles Schwab & Co., Inc.

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise and Hold financial

"Common | 11/19/2024 | Exercise and Hold"

Charles Schwab & Co., Inc. technical

"Common | Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What does Axsome Therapeutics' Form 144 (AXSM) report?

It reports proposed or completed sales of restricted Common stock by a holder. The excerpt shows two 6,000-share transactions dated 05/29/2026 and 06/01/2026 with reported dollar amounts of $1,400,783.00 and $1,381,798.00.

Who is the broker named in the Axsome (AXSM) Form 144?

The filing names Charles Schwab & Co., Inc. as the broker. The excerpt provides the broker address and lists transactions routed through that brokerage for the reported dates.

How many shares outstanding does the filing show for Axsome (AXSM)?

The excerpt shows 51,459,766 shares outstanding as of 06/02/2026. This figure appears on the securities line in the provided content and is tied to the 06/02/2026 date.

Does the Form 144 excerpt show an option exercise or withholding?

Yes. The excerpt includes an "Exercise and Hold" entry dated 11/19/2024 with cash indicated. The filing lists "Cash" as the cash-flow treatment for that exercise in the provided lines.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	5537	1236885.00	51459766	06/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/19/2024	Exercise and Hold	Axsome Therapeutics, Inc.			5537	11/19/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK COLEMAN ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007	Axsome Therapeutics, Inc.	05/29/2026	6000	1400783.00
MARK COLEMAN ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007	Axsome Therapeutics, Inc.	06/01/2026	6000	1381798.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)